Human ocular-derived virus-specific CD4+ T cells control Varicella zoster virus replication in human retinal pigment epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 2, 2009, Pages 743-751

  Milikan, Johannes C M ^a,b   Baarsma, G Seerp ^b   Kuijpers, Robert W A M ^a   Osterhaus, Albert D M E ^a   Verjans, Georges M G M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROTTERDAM EYE HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; HLA ANTIGEN CLASS 2; VIRUS PROTEIN; LEUKOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL CLONE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HERPES ZOSTER; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; INTERFERON PRODUCTION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; VIRUS REPLICATION; VIRUS STRAIN; ANTIGEN PRESENTING CELL; CELL LINE; DRUG EFFECT; HERPES ZOSTER OPHTHALMICUS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; RETINITIS; VIROLOGY;

ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HERPES ZOSTER OPHTHALMICUS; HERPESVIRUS 3, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERFERON-GAMMA; RETINAL PIGMENT EPITHELIUM; RETINITIS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 59449101493     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2611     Document Type: Article

References (72)

1. Cohen JI, Straus SE, Arvin AM. Varicella-zoster virus: replication, pathogenesis, and management. In: Knipe DM, Howley PM, eds. Fields Virology. Vol. 2, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:2774-2818.
2. Roizman B, Knipe DM, Whitley RJ. Herpes simplex viruses. In: Knipe DM, Howley PM, eds. Fields Virology. Vol 2, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:2502-2601.
3. Koelle DM, Corey L. Herpes simplex: insights on pathogenesis and possible vaccines. Ann Rev Med. 2008;59:381-395.
4. Arvin AM. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model. Herpes. 2006;13:75-80.
5. von Andrian UH, Mackay CR. T-cell function and migration: two sides of the same coin. N Engl J Med. 2000;343:1020-1034.
6. Ritterband DC, Friedberg DN. Virus infections of the eye. Rev Med Virol. 1998;8:187-201.
7. Liesegang TJ. Varicella-zoster virus eye disease. Cornea. 1999;18: 511-531.
8. Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea. 2001;20:1-13.
9. Remeijer L, Osterhaus A, Verjans G. Human herpes simplex virus keratitis: the pathogenesis revisited. Ocul Immunol Inflamm. 2004;12:255-285.
10. Green LK, Pavan-Langston D. Herpes simplex ocular inflammatory disease. Int Ophthalmol Clin. 2006;46:27-37.
11. Biswas PS, Rouse BT. Early events in HSV keratitis: setting the stage for a blinding disease. Microbes Infect. 2005;7:799-810.
12. Lepisto AJ, Frank GM, Hendricks RL. How herpes simplex virus type 1 rescinds corneal privilege. Chem Immunol Allergy. 2007; 92:203-212.
13. + T cells in corneas of herpetic stromal keratitis patients. J Infect Dis. 1998; 177:484-488.
14. Seo SK, Gebhardt BM, Lim HY, et al. Murine keratocytes function as antigen-presenting cells. Eur J Immunol. 2001;31:3318-3328.
15. Madhavan HN, Priya K, Biswas J. Current perspectives of herpesviral retinitis and choroiditis. Indian J Pathol Microbiol. 2004;47: 453-468.
16. Kezuka T, Atherton SS. Acute retinal necrosis. Chem Immunol Allergy. 2007;92:244-253.
17. Milikan JC, Kinchington PR, Baarsma GS, Kuijpers RW, Osterhaus AD, Verjans GM. Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virusinduced uveitis. Invest Ophthalmol Vis Sci. 2007;48:3689-3697.
18. Culbertson WW, Blumenkranz MS, Haines H, Gass DM, Mitchell KB, Norton EW. The acute retinal necrosis syndrome, 2: histopathology and etiology. Ophthalmology. 1982;89:1317-1325.
19. Culbertson WW, Blumenkranz MS, Pepose JS, Stewart JA, Curtin VT. Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology. 1986;93:559-569.
20. Kuppermann BD, Quiceno JI, Wiley C, et al. Clinical and histopathologic study of Varicella zoster virus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1994;118:589-600.
21. Young RW. The renewal of photoreceptor cell outer segments. J Cell Biol. 1967;33:61-72.
22. Schraermeyer U, Heimann K. Current understanding on the role of retinal pigment epithelium and its pigmentation. Pigment Cell Res. 1999;12:219-236.
23. Holtkamp GM, Kijlstra A, Peek R, et al. RPE-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res. 2001;20:29-48.
24. Zamiri P, Sugita S, Streilein JW. Immunosuppressive properties of the pigmented epithelial cells and the subretinal space. Chem Immunol Allergy. 2007;92:86 -93.
25. Chan CC, Detrick B, Nussenblatt RB, Palestine AG, Fujikawa LS, Hooks JJ. HLA-DR antigens on retinal pigment epithelial cells from patients with uveitis. Arch Ophthalmol. 1986;104:725-729.
26. Liversidge JM, Sewell HF, Forrester JV. Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma. Clin Exp Immunol. 1988;73:489-494.
27. Percopo CM, Hooks JJ, Shinohara T, Caspi R, Detrick B. Cytokinemediated activation of a neuronal retinal resident cell provokes antigen presentation. J Immunol. 1990;145:4101-4107.
28. Verjans GMGM, Feron EJ, Dings ME, et al. T-cells specific for the triggering virus infiltrate the eye in patients with herpes simplex virus-mediated acute retinal necrosis. J Infect Dis. 1998;178:27-34.
29. Karl MO, Valtink M, Bednarz J, Engelmann K. Cell culture conditions affect RPE phagocytic function. Graefes Arch Clin Exp Ophthalmol. 2007;245:981-991.
30. Zerboni L, Sommer M, Ware CF, Arvin AM. Varicella-zoster virus infection of a human CD4-positive T-cell line. Virology. 2000;270: 278-285.
31. Lee-MacAry AE, Ross EL, Davies D, et al. Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. J Immunol Methods. 2001; 252:83-92.
32. van Baalen CA, Kwa D, Verschuren EJ, et al. Fluorescent antigentransfected target T-cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity. J Infect Dis. 2005;192:1183-1190.
33. Schmidt-Chanasit J, Bleymehl K, Rabenau HF, Ulrich RG, Cinatl J Jr, Doerr HW. In vitro replication of varicella-zoster virus in human retinal pigment epithelial cells. J Clin Microbiol. 2008;46:2122-2124.
34. Willermain F, Caspers-Velu L, Baudson N, et al. Role and expression of CD40 on human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:3485-3491.
35. Kanuga N, Winton HL, Beauchéne L, et al. Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studies. Invest Ophthalmol Vis Sci. 2002;43:546-555.
36. Milikan JC, Kuijpers RW, Baarsma GS, Osterhaus AD, Verjans GM. Characterization of the varicella zoster virus (VZV)-specific intraocular T-cell response in patients with VZV-induced uveitis. Exp Eye Res. 2006;83:69 -75.
37. Trapani JA, Sutton VR, Smyth MJ. CTL granules: evolution of vesicles essential for combating virus infections. Immunol Today. 1999;20:351-356.
38. Appay V. The physiological role of cytotoxic CD4(+) T-cells: the holy grail? Clin Exp Immunol. 2004;138:10-13.
39. De Groet-Mijnes JD, RothoOva A, Van Loon AM, et al. Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis. Am J Ophthalmol. 2006;141:313-318.
40. Cinatl J Jr, Michaelis M, Fleckenstein C, et al. West Nile virus infection induces interferon signalling in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2006;47:645-651.
41. Wang Y, Detrick B, Hooks JJ. Coronavirus (JHM) replication within the retina: analysis of cell tropism in mouse retinal cell cultures. Virology. 1993;193:124-137.
42. Huemer HP, Larcher C, Kirchebner W, Klingenschmid J, Göttinger W, Irschick EU. Susceptibility of human retinal pigment epithelial cells to different viruses. Graefes Arch Clin Exp Ophthalmol. 1996;234:177-185.
43. Atherton SS, Streilein JW. Two waves of virus following anterior chamber inoculation of HSV-1. Ocul Immunol Inflamm. 2007;15: 195-204.
44. Fuller S, von Bonsdorff CH, Simons K. Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK. Cell. 1984;38:65-77.
45. Rodriguez D, Rodriguez JR, Ojakian GK, Esteban M. Vaccinia virus preferentially enters polarized epithelial cells through the basolateral surface. J Virol. 1991;65:494-498.
46. Tugizov S, Maidji E, Pereira L. Role of apical and basolateral membranes in replication of human cytomegalovirus in polarized retinal pigment epithelial cells. J Gen Virol. 1996;77:61-74.
47. Galen B, Cheshenko N, Tuyama A, Ramratnam B, Herold BC. Access to nectin favors herpes simplex virus infection at the apical surface of polarized human epithelial cells. J Virol. 2006;80: 12209-12218.
48. Zhu Z, Gershon MD, Ambron R, Gabel C, Gershon AA. Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin. Proc Natl Acad Sci U S A. 1995;92: 3546-3550.
49. Li Q, Ali MA, Cohen JI. Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread. Cell. 2006;127:305-316.
50. Holtkamp GM, De Vos AF, Peek R, Kijlsta A. Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGFβ2) by human retinal pigment epithelial cells. Clin Exp Immunol. 1999;118:35-40.
51. Chen M, Forrester JV, Xu H. Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. Exp Eye Res. 2007;84:635-645.
52. Elner VM, Scales W, Elner SG, Danforth J, Kunkel SL, Strieter RM. Interleukin-6 (IL-6) gene expression and secretion by cytokinestimulated human retinal pigment epithelial cells. Exp Eye Res. 1992;54:361-368.
53. Crane IJ, Kuppner MC, McKillop-Smith S, Wallace CA, Forrester JV. Cytokine regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) production by human retinal pigment epithelial cells. Clin Exp Immunol. 1999;115:288-293.
54. Fukuoka Y, Strainic M, Medof ME. Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a. Clin Exp Immunol. 2003;131:248-253.
55. Elner VM, Strieter RM, Elner SG, Baggiolini M, Lindley I, Kunkel SL. Neutrophil chemotactic factor (IL-8) gene expression by cytokinetreated retinal pigment epithelial cells. Am J Pathol. 1990;136: 745-750.
56. Bian ZM, Elner SG, Strieter RM, et al. Glycated serum albumin induces chemokine gene expression in human retinal pigment epithelial cells. J Leukoc Biol. 1996;60:405-414.
57. Bian ZM, Elner SG, Yoshida A, Kunkel SL, Su J, Elner VM. Activation of p38, ERK1/2 and NIK pathways is required for IL-1beta and TNF-alpha-induced chemokine expression in human retinal pigment epithelial cells. Exp Eye Res. 2001;73:111-121.
58. Kaestel CG, Lovato P, Odum N, Nissen MH, Ropke C. The immune privilege of the eye: human retinal pigment epithelial cells selectively modulate T-cell activation in vitro. Curr Eye Res. 2005;30: 375-383.
59. Ishida K, Panjwani N, Cao Z, Streilein JW. Participation of pigment epithelium in ocular immune privilege, 3: epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms. Ocul Immunol Inflamm. 2003;11: 91-105.
60. Kaestel CG, Jorgensen A, Nielsen M, et al. Human retinal pigment epithelial cells inhibit proliferation and IL2R expression of activated T cells. Exp Eye Res. 2002;74:627-637.
61. Sun D, Enzmann V, Lei S, Sun SL, Kaplan HJ, Shao H. Retinal pigment epithelial cells activate uveitogenic T cells when they express high levels of MHC class II molecules, but inhibit T cell activation when they express restricted levels. J Neuroimmunol. 2003;144:1-8.
62. Liversidge J, McKay D, Mullen G, Forrester JV. Retinal pigment epithelial cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms. Cell Immunol. 1993;149:315-330.
63. Liversidge J, Forrester JV. Antigen processing and presentation in the eye: a review. Curr Eye Res. 1992;11:49 -58.
64. Gregerson DS, Heuss ND, Lew KL, McPherson SW, Ferrington DA. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy. Invest Ophthalmol Vis Sci. 2007;48:4654-4663.
65. Kirschner DE, Chang ST, Riggs TW, Perry N, Linderman JJ. Toward a multiscale model of antigen presentation in immunity. Immunol Rev. 2007;216:93-118.
66. Xu H, Dawson R, Forrester JV, Liversidge J. Identification of novel dendritic cell populations in normal mouse retina. Invest Ophthalmol Vis Sci. 2007;48:1701-1710.
67. Skoberne M, Schenk S, Hof H, Geginat G. Cross-presentation of Listeria monocytogenes-derived CD4 T cell epitopes. J Immunol. 2002;169:1410-1418.
68. Christensen JP, Cardin RD, Branum KC, Doherty PC. CD4+ T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc Natl Acad Sci U S A. 1999;96:5135-5140.
69. Heller KN, Gurer C, Munz C. Virus-specific CD4+ T-cells: ready for direct attack. J Exp Med. 2006;203:805-808.
70. Appay V, Zaunders JJ, Papagno L, et al. Characterization of CD4(+) CTLs ex vivo. J Immunol. 2002;168:5954-5958.
71. Koelle DM, Frank JM, Johnson ML, Kwok WW. Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions. J Virol. 1998;72:7476-7483.
72. Cohrs RJ, Gilden DH, Mahalingam R. Varicella zoster virus latency, neurological disease and experimental models: an update. Front Biosci. 2004;9:751-762.